GSK PLC (GSK)

Industry Drug Manufacturers - General
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

2,101.00p

Buy

2,103.00p

arrow-up50.50p (+2.45%)

Prices updated at 01 Apr 2026, 16:53 BST
| Prices minimum 15 mins delay
|
Prices in GBX
GlaxoSmithKline PLC creates, discovers, develops, manufactures and markets pharmaceutical products including respiratory and antiviral, vaccines, over-the-counter (OTC) medicines and health-related consumer products.
FTSE All-Share
arrow-up1.9%
LSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.

Most recent dividend payment

0.180
Cash Dividend
19 Feb 2026
04 Feb 2026
20 Feb 2026
09 Apr 2026

Total dividend yield

Dividend history and forecast data table

YearDividend per shareDividend growth (%)
20260.1800-
20250.64000.05
20240.61000.09
20230.5575-0.27
20220.7625-0.24
20211.0000-
20201.0000-
20191.0000-
20181.0000-
20171.0000-

Total dividend yield data table

Year
chevron-l-regular
chevron-r-regular
Dividend yield (%)Buyback yield (%)
20263.201.65
20253.511.52
20244.53-
20233.84-
20225.30-
20214.98-
20205.96-
20194.50-
20185.36-
20176.05-

Dividend per share

% of earnings paid to shareholders

Dividend per share data table

YearDividend per share
20260.1800
20250.6400
20240.6100
20230.5575
20220.7625
20211.0000
20201.0000
20191.0000
20181.0000
20171.0000

% of earnings paid to shareholders data table

YearPayout ratio (%)
202646.11
202547.37
202498.85
202337.47
202278.88
202193.90
202063.29
201987.62
2018213.90
2017169.13
Latest Financial Report as of 31 Mar 2026
Dividend amount and dividend per share are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2026 Morningstar. All rights reserved.